Reward-related brain structures are smaller in patients with schizophrenia and comorbid metabolic syndrome

J. de Nijs*, H. G. Schnack, M. G.J.C. Koevoets, M. Kubota, R. S. Kahn, N. E.M. van Haren, W. Cahn

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective: Metabolic syndrome (MS) is highly prevalent in schizophrenia and often a consequence of unhealthy behaviour. Reward-related brain areas might be associated with MS, since they play a major role in regulating health behaviour. This study examined the relationship between MS and brain volumes related to the reward system in schizophrenia. Method: We included patients with schizophrenia, with MS (MS+; n = 23), patients with schizophrenia, without MS (MS−; n = 48), and healthy controls (n = 54). Global brain volumes and volumes of (sub)cortical areas, part of the reward circuit, were compared between patients and controls. In case of a significant brain volume difference between patients and controls, the impact of MS in schizophrenia was examined. Results: Patients had smaller total brain (TB; P = 0.001), GM (P = 0.010), larger ventricles (P = 0.026), and smaller reward circuit volume (P < 0.001) than controls. MS+ had smaller TB (P = 0.017), GM (P = 0.008), larger ventricles (P = 0.015), and smaller reward circuit volume (P = 0.002) than MS−. MS+ had smaller orbitofrontal cortex (OFC; P = 0.002) and insula volumes (P = 0.005) and smaller OFC (P = 0.008) and insula cortical surface area (P = 0.025) compared to MS−. Conclusion: In schizophrenia, structural brain volume reductions in areas of the reward circuitry appear to be related to comorbid MS.

Original languageEnglish
Pages (from-to)581-590
Number of pages10
JournalActa Psychiatrica Scandinavica
Volume138
Issue number6
DOIs
Publication statusPublished - 1 Dec 2018

Keywords

  • metabolic syndrome
  • neuroimaging
  • schizophrenia

Fingerprint

Dive into the research topics of 'Reward-related brain structures are smaller in patients with schizophrenia and comorbid metabolic syndrome'. Together they form a unique fingerprint.

Cite this